Curesponse has developed a 3-dimensional tissue culture system for modeling cancer growth and drug response. The platform, preserves the cancer tissue architecture (including vasculature and immune system) accurately reflecting the cancer growth found in the body.
1. Drug selection by physician & genomics
2. Cancer sample
removed from patient
3. 3D tissue culture system
4. Evaluation by a pathologist
Curesponse’s technology represents the next step in personalized cancer medicine, moving prediction capabilities beyond genomics and into the world of functional response on living patient cells.